Our team has a proven track record.

Daphne Zohar

Founder, CEO & Board Member

Daphne Zohar is the Founder, CEO and Board Member of Seaport Therapeutics. Previously, she was the Founder, CEO and Board Member of PureTech Health, where she also co-founded PureTech’s entities, including Karuna Therapeutics, which was acquired by Bristol Myers Squibb for $14 billion…

Steven Paul, M.D.

Founder, Board Chair

Dr. Steven Paul is Founder and Chair of the Board of Directors at Seaport Therapeutics. He has over 40 years of experience as a physician-scientist specializing in neuroscience and molecular neuropharmacology as well as CNS drug discovery and development. Dr. Paul previously…

Antony Loebel, M.D.

Chief Medical Officer, President of Clinical Development

Antony Loebel, M.D. is the Chief Medical Officer and President of Clinical Development at Seaport Therapeutics. He was most recently the President and Chief Executive Officer of Sunovion Pharmaceuticals, a global pharmaceutical company focused on CNS drug development…

Michael Chen, Ph.D.

Co-Founder, Chief Scientific Officer

Michael Chen, Ph.D., is Co-founder and Chief Scientific Officer of Seaport Therapeutics. In his most recent role, he was Head of Innovation at PureTech Health, where he oversaw the rapid advancement of the neuropsychiatric medicines that led to the launch of Seaport Therapeutics…

Lana Gladstein, J.D.

General Counsel

Lana Gladstein, J.D. is General Counsel at Seaport Therapeutics. She has over two decades of legal expertise, including corporate governance, navigating M&A transactions, licensing and partnerships, and intellectual property matters. Most recently, she was the Group General Counsel at APRINOIA Therapeutics…

Eric Green

Chief Operating Officer

Eric Green is the Chief Operating Officer at Seaport Therapeutics. He is responsible for implementing strategies to support the growth and development across the organization. Most recently, Mr. Green was SVP, Head of Development Programs at Alnylam Pharmaceuticals…

Lauren White

Chief Financial Officer

Lauren White is Chief Financial Officer at Seaport Therapeutics. She has over 22 years of corporate finance, accounting, strategic partnering and investor relations expertise. Most recently, Ms. White served as the Chief Financial Officer at ImmunoGen (NASDAQ: IMGN) prior to its acquisition by AbbVie (NYSE: ABBV) for $10.1 billion in 2024…

Steven Paul, M.D.

Founder, Board Chair

Dr. Steven Paul is Founder and Chair of the Board of Directors at Seaport Therapeutics. He has over 40 years of experience as a physician-scientist specializing in neuroscience and molecular neuropharmacology as well as CNS drug discovery and development. Dr. Paul previously…

Daphne Zohar

Founder, CEO & Board Member

Daphne Zohar is the Founder, CEO and Board Member of Seaport Therapeutics. Previously, she was the Founder, CEO and Board Member of PureTech Health, where she also co-founded PureTech’s entities, including Karuna Therapeutics, which was acquired by Bristol Myers Squibb for $14 billion…

Robert Nelsen

Board Member

Robert Nelsen is a member of the Board of Directors at Seaport. He is co-founder and a Managing Director of ARCH Venture Partners. He joined ARCH at its founding and played a significant role in the creation, early sourcing, financing…

Jim Healy, M.D, Ph.D.

Board Member

Jim Healy, M.D., Ph.D., is a member of the Board of Directors at Seaport. He is Managing Partner at Sofinnova Investments. Throughout Jim’s twenty-year career with Sofinnova he has invested in thirty two companies…

Denice Torres, J.D.

Board Member

Denice Torres, J.D. is a member of the Board of Directors at Seaport. She brings notable public and private board experience to Seaport, including a position on the Board of Directors at Karuna Therapeutics until its acquisition by Bristol Myers Squibb in March 2024…

David Wheadon, M.D.

Board Member

David Wheadon, M.D., is a member of the Board of Directors at Seaport. He most recently served as Senior Vice President, Global Regulatory Affairs, Patient Safety and Quality Assurance at AstraZeneca…

Eric Elenko, Ph.D.

Board Member

Eric Elenko, Ph.D., is a member of the Board of Directors at Seaport. He is also co-founder and President at PureTech where he has led the development of a number of programs, including two that have received US FDA clearance and a third (KarXT)…

Bharatt Chowrira, Ph.D., J.D.

Board Member

Bharatt Chowrira, Ph.D., J.D., is a member of the Board of Directors at Seaport. He serves as Chief Executive Officer and as a member of the Board of Directors at PureTech. Dr. Chowrira has been a member of the PureTech….

Jason Pitts

Board Member

Jason Pitts is a Board Member at Seaport. He is a Vice President at General Atlantic, a leading global growth investor, and focuses on investments in the Life Sciences sector. Before joining General Atlantic in 2021, Jason was a Principal at Sofinnova Investments….

Sandi Peterson

Board Member

Sandi Peterson is a Board Member at Seaport. She also serves on the Microsoft Board of Directors as the lead independent director. Ms. Peterson is an Operating Partner at Clayton, Dubilier & Rice, (CD&R), a private investment firm…

Courtney Wallace

Board Advisor

Courtney Wallace is a Board Observer at Seaport. She is a Venture Partner at Third Rock Ventures, where she focuses on the creation, development, and strategy of new biotechnology companies…

Maurizio Fava, MD

Psychiatrist-in-Chief, Massachusetts General Hospital Department of Psychiatry, and Slater Family Professor of Psychiatry, Harvard Medical School

Stephen Brannan, MD

Neuroscience drug development expert, former Chief Medical Officer at Karuna Therapeutics (acquired by Bristol Myers Squibb)

Murray Stein, MD, MPH, FRCPC

Distinguished Professor of Psychiatry and Public Health, UC San Diego

Samantha Meltzer-Brody, MD
Assad Meymandi Distinguished Professor and Chair of the Department of Psychiatry at the University of North Carolina at Chapel Hill

Seaport Therapeutics
6 Tide Street
Seaport Boston, MA 02210

info@seaporttx.com
Privacy Policy
Terms of Use

© 2024 Seaport Therapeutics